Cargando…

Immunotoxicity Considerations for Next Generation Cancer Nanomedicines

Although interest and funding in nanotechnology for oncological applications is thriving, translating these novel therapeutics through the earliest stages of preclinical assessment remains challenging. Upon intravenous administration, nanomaterials interact with constituents of the blood inducing a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hannon, Gary, Lysaght, Joanne, Liptrott, Neill J., Prina‐Mello, Adriele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6774033/ https://www.ncbi.nlm.nih.gov/pubmed/31592123 http://dx.doi.org/10.1002/advs.201900133

Ejemplares similares

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou, Christina, et al.
Publicado: (2016)

Thermal ablation in pancreatic cancer: A scoping review of clinical studies
por: Farmer, William, et al.
Publicado: (2022)

Comparing the Effects of Intracellular and Extracellular Magnetic Hyperthermia on the Viability of BxPC-3 Cells
por: Hannon, Gary, et al.
Publicado: (2020)

Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls
por: Giannakou, Christina, et al.
Publicado: (2020)

Consideration of pathways for immunotoxicity of per- and polyfluoroalkyl substances (PFAS)
por: Ehrlich, Veronika, et al.
Publicado: (2023)

Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies
por: Urbán, Patricia, et al.
Publicado: (2018)

Advances in nanomedicine drug delivery applications for HIV therapy
por: Curley, Paul, et al.
Publicado: (2017)

Next-Generation Nanomedicine Approaches for the Management of Retinal Diseases
por: Mahaling, Binapani, et al.
Publicado: (2023)

Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease
por: Li, De-feng, et al.
Publicado: (2022)

Neurological Immunotoxicity from Cancer Treatment
por: Wesley, Sarah F., et al.
Publicado: (2021)

Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials
por: Tutty, Melissa Anne, et al.
Publicado: (2022)

Arsenic immunotoxicity: a review
por: Dangleben, Nygerma L, et al.
Publicado: (2013)

Mechanisms of Immunotoxicity: Stressors and Evaluators
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment
por: Chakraborty, Kasturee, et al.
Publicado: (2022)

Preclinical Development of Orally Inhaled Drugs (OIDs)—Are Animal Models Predictive or Shall We Move Towards In Vitro Non-Animal Models?
por: Movia, Dania, et al.
Publicado: (2020)

Magnetic Nanoparticles in Cancer Theranostics
por: Gobbo, Oliviero L., et al.
Publicado: (2015)

Development of next generation nanomedicine-based approaches for the treatment of cancer: we've barely scratched the surface
por: Tracey, Shannon R., et al.
Publicado: (2021)

ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC MultiDrug Resistance
por: Movia, Dania, et al.
Publicado: (2019)

Exploring the Immunotoxicity of Carbon Nanotubes
por: Yu, Yanmei, et al.
Publicado: (2008)

Microcystin-LR Induced Immunotoxicity in Mammals
por: Lone, Yaqoob, et al.
Publicado: (2016)

In vivo assessment of immunotoxicity
por: Munson, Albert E., et al.
Publicado: (1982)

Multilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs
por: Movia, Dania, et al.
Publicado: (2018)

Practical Considerations for Next-Generation Adjuvant Development and Translation
por: Lykins, William R., et al.
Publicado: (2023)

Biomarkers of Immunotoxicity for Environmental and Public Health Research
por: Duramad, Paurene, et al.
Publicado: (2011)

Immunotoxicity of Carbon-Based Nanomaterials, Starring Phagocytes
por: Svadlakova, Tereza, et al.
Publicado: (2022)

Heterogeneity of Intestinal Tissue Eosinophils: Potential Considerations for Next-Generation Eosinophil-Targeting Strategies
por: Masterson, Joanne C., et al.
Publicado: (2021)

Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity
por: Lee, Yeon Kyung, et al.
Publicado: (2014)

In vitro Alternatives to Acute Inhalation Toxicity Studies in Animal Models—A Perspective
por: Movia, Dania, et al.
Publicado: (2020)

Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity
por: Tutty, Melissa Anne, et al.
Publicado: (2022)

Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo
por: Fröhlich, Eleonore
Publicado: (2015)

Immunotoxic Effects Induced by Microcystins and Cylindrospermopsin: A Review
por: Diez-Quijada, Leticia, et al.
Publicado: (2021)

Microcystin-Induced Immunotoxicity in Fishes: A Scoping Review
por: Lin, Wang, et al.
Publicado: (2021)

Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics
por: Mao, Yuqiang, et al.
Publicado: (2020)

New approaches to immunotoxicity testing.
por: Archer, D L
Publicado: (1982)

Theoretical Considerations for Next-Generation Proteomics
por: Palmblad, Magnus
Publicado: (2021)

Investigating Molecular Mechanisms of Immunotoxicity and the Utility of ToxCast for Immunotoxicity Screening of Chemicals Added to Food
por: Naidenko, Olga V., et al.
Publicado: (2021)

Nanomedicine Strategies for Heating “Cold” Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
por: Yang, Yuqi, et al.
Publicado: (2022)

Internalization of ferromagnetic nanowires by different living cells
por: Prina-Mello, Adriele, et al.
Publicado: (2006)

Editorial: Use of 3D Models in Drug Development and Precision Medicine - Advances and Outlook
por: Prina-Mello, Adriele, et al.
Publicado: (2021)

An inter-laboratory comparison of an NLRP3 inflammasome activation assay and dendritic cell maturation assay using a nanostructured lipid carrier and a polymeric nanomedicine, as exemplars
por: Vandebriel, Rob J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0m7er3jk4olmlarrgo6tog6jce